Table 3.
Hazard of waitlisting before and after 2014 Kidney Allocation System policies among patients with first onset of kidney failure (2005–2017) by sex
| Models | Women (versus Men) Hazard Ratio (95% Confidence Interval) | |
|---|---|---|
| Access to Waitlisting | Before 2014 Kidney Allocation System | After 2014 Kidney Allocation System |
| Unadjusted model | 0.79 (0.78 to 0.80) | 0.83 (0.82 to 0.85) |
| Minimally adjusted modela (Model 1) | 0.86 (0.85 to 0.87) | 0.90 (0.89 to 0.92) |
| Fully adjusted modelb (Model 2) | 0.89 (0.88 to 0.89) | 0.94 (0.92 to 0.96) |
| Fully adjusted model (Model 2) stratified by cause of kidney failure | ||
| Type 2 diabetes | 0.72 (0.71 to 0.73) | 0.77 (0.74 to 0.79) |
| Type 1 diabetes | 0.96 (0.93 to 0.99) | 1.03 (0.96 to 1.11) |
| Hypertension | 0.90 (0.88 to 0.92) | 0.94 (0.90 to 0.98) |
| Cystic disease | 1.04 (1.00 to 1.07) | 1.18 (1.11 to 1.25) |
| GN | 0.95 (0.93 to 0.97) | 0.98 (0.94 to 1.02) |
| Other | 1.13 (1.11 to 1.16) | 1.18 (1.11 to 1.24) |
a
Adjusted for attributed cause of kidney failure, age, race/ethnicity, and body mass index (BMI).
b
Adjusted for attributed cause of kidney failure, age, race/ethnicity, BMI, yr of first kidney failure treatment, median zip code household income, insurance coverage, Organ Procurement and Transplant Network region, smoking, chronic obstructive pulmonary disease, cancer, coronary artery disease, congestive heart failure, stroke or transient ischemic attack, peripheral vascular disease.